HomeImpediMed Limited

ImpediMed Limited

ImpediMed Announces First Patient Enrolled at Scripps Memorial Hospital in 200-Patient Heart Failure Trial

10/15/18: The study is designed to demonstrate the extent to which changes in SOZO® BIS measurements preempt patient-reported symptoms of HF that lead to hospital readmissions.

SOZO Device Abstract Presentations at Key Scientific Cardiology Meetings Demonstrate Utilization of Bioimpedance Spectroscopy for Heart Failure Patients

SOZO device will be presented during poster presentations by A.J. Accardi, M.D. at the upcoming American Heart Congress – CVD, October 5-6, 2018, Los Angeles.